Zenuzolac (VGX-1027) is under development for the treatment of severe pneumonitis caused by Coronavirus Disease 2019 (COVID-19), inflammatory diseases and diabetic nephropathy. The drug candidate is ...

Zenuzolac is under clinical development by Inovio Pharmaceuticals and currently in Phase I for Diabetic Nephropathy.

Cell competition in epithelial tissue eliminates transformed cells expressing activated oncoproteins to maintain epithelial homeostasis. Although the process is now understood to be of mechanochemical ...

The debate about adopting the term scientist, and musings on how the content in Nature has evolved over the years, in this week’s pick from the journal’s archive.